Use of Muscle Ultrasound to Predict Function
Muscle Ultrasound as a Predictor of Functional Status in Spinal Cord Injury Patients
1 other identifier
interventional
80
1 country
1
Brief Summary
Establish if change from the baseline in ultrasound muscle parameters over 2 months of rehabilitation correlates with functional status of SCI patients at the end of rehabilitation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2020
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedFirst Posted
Study publicly available on registry
March 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2022
CompletedApril 28, 2022
April 1, 2022
2 years
January 29, 2020
April 26, 2022
Conditions
Outcome Measures
Primary Outcomes (16)
Functional Independence Score
An 18-item of physical, psychological and social function (graded from 1-7)
Baseline (Performed on admission to inpatient rehabilitation)
Functional Independence Score
An 18-item of physical, psychological and social function (graded from 1-7)
Performed at 1-2 months after starting rehabilitation
Functional Independence Score
An 18-item of physical, psychological and social function (graded from 1-7)
Performed at 3-6 months
Functional Independence Score
An 18-item of physical, psychological and social function (graded from 1-7)
Performed at 1 year
Spinal Cord Independence Measure (SCIM) III
It is used by health care practitioners to assess and grade the functional status of a person based on the level of assistance he or she requires, in patients with spinal cord injury. Only the patient's indoor mobility subscore will be assessed from abilities, graded from 0-8.
Baseline (Performed on admission to inpatient rehabilitation)
Spinal Cord Independence Measure (SCIM) III
It is used by health care practitioners to assess and grade the functional status of a person based on the level of assistance he or she requires, in patients with spinal cord injury. Only the patient's indoor mobility subscore will be assessed from abilities, graded from 0-8.
Performed at 1-2 months after starting rehabilitation
Spinal Cord Independence Measure (SCIM) III
It is used by health care practitioners to assess and grade the functional status of a person based on the level of assistance he or she requires, in patients with spinal cord injury. Only the patient's indoor mobility subscore will be assessed from abilities, graded from 0-8.
Performed at 3-6 months
Spinal Cord Independence Measure (SCIM) III
It is used by health care practitioners to assess and grade the functional status of a person based on the level of assistance he or she requires, in patients with spinal cord injury. Only the patient's indoor mobility subscore will be assessed from abilities, graded from 0-8.
Performed at 1 year
ASIA score
This is an assessor administered test that systematically examines the dermatomes and myotomes in spinal cord patients through testing the strength and sensation
Baseline (Performed on admission to inpatient rehabilitation)
ASIA score
This is an assessor administered test that systematically examines the dermatomes and myotomes in spinal cord patients through testing the strength and sensation
Performed at 1-2 months after starting rehabilitation
ASIA score
This is an assessor administered test that systematically examines the dermatomes and myotomes in spinal cord patients through testing the strength and sensation
Performed at 3-6 months
ASIA score
This is an assessor administered test that systematically examines the dermatomes and myotomes in spinal cord patients through testing the strength and sensation
Performed at 1 year
Walking Index for Spinal Cord Injury II (WISCI II)
A walking scale used by health care practitioners to grade the walking ability of SCI patients.
Baseline (Performed on admission to inpatient rehabilitation)
Walking Index for Spinal Cord Injury II (WISCI II)
A walking scale used by health care practitioners to grade the walking ability of SCI patients.
Performed at 1-2 months after starting rehabilitation
Walking Index for Spinal Cord Injury II (WISCI II)
A walking scale used by health care practitioners to grade the walking ability of SCI patients.
Performed on 3-6 months
Walking Index for Spinal Cord Injury II (WISCI II)
A walking scale used by health care practitioners to grade the walking ability of SCI patients.
Performed on 1 year
Secondary Outcomes (8)
Range of motion of elbow, hip and knee
Baseline (Performed on admission to inpatient rehabilitation)
Range of motion of elbow, hip and knee
Performed at 1-2 months after starting rehabilitation
Range of motion of elbow, hip and knee
Performed at 3-6 months
Range of motion of elbow, hip and knee
Performed at 1 year
Spasticity
Baseline (Performed on admission to inpatient rehabilitation)
- +3 more secondary outcomes
Study Arms (1)
Muscle ultrasound
EXPERIMENTALMuscle ultrasound will be performed for the patient on admission and at 1-2 months from inpatient rehabilitation.
Interventions
The muscle thickness and muscle quality will be assessed on ultrasound
Eligibility Criteria
You may qualify if:
- First ever acute SCI
- Age 21-65 years
- Presence of weakness in the lower limbs (defined as either ASIA A, B, C or D)
- Independent in ambulation prior to onset of SCI
- Able to understand study procedures and sign informed consent
- Clinical suitability for rehabilitation
You may not qualify if:
- Presence of premorbid lower musculoskeletal conditions eg contractures, fractures, previous operations, that prevents proper ultrasound assessment of the affected limb
- Cardiorespiratory conditions eg congestive cardiac failure (EF\<40%), chronic arrhythmias, COPD stage 3-4
- End stage illness, end stage renal failure, life expectancy \<6 months
- Other active neurological conditions
- Botulinum toxin injection over the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tan Tock Seng Hospital Rehabilitation Centre
Singapore, 569766, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Tay, MD
Tan Tock Seng Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2020
First Posted
March 11, 2020
Study Start
February 1, 2020
Primary Completion
January 30, 2022
Study Completion
January 30, 2022
Last Updated
April 28, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share